Mobile version of Hanspub

文章引用说明 更多>> (返回到该文章)

G. Goss, F. A. Shepherd, S. Laurie, et al. A phase I and pharmacokinetic study of daily oral cediranib, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with cisplatin and gem-citabine in patients with advanced non-small cell lung cancer: A study of the National Cancer Institute of Canada Clinical Trials Group. European Journal of Cancer, 2009, 45(5): 782-788.

被以下文章引用: